Standard

Targeted next-generation sequencing techniques: From primer design to sophisticated library construction. / Koryukov, Maxim; Mikheeva, Regina; Kechin, Andrey.

In: Methods, Vol. 253, 09.2026, p. 31-48.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Koryukov M, Mikheeva R, Kechin A. Targeted next-generation sequencing techniques: From primer design to sophisticated library construction. Methods. 2026 Sept;253:31-48. doi: 10.1016/j.ymeth.2026.05.004

Author

BibTeX

@article{1db73939142e46e6b7cc00ad52308574,
title = "Targeted next-generation sequencing techniques: From primer design to sophisticated library construction",
abstract = "Targeted Next-Generation Sequencing (tNGS) represents a cornerstone technology in modern clinical diagnostics and biological research. Widely adopted by clinical laboratories, tNGS provides a robust and cost-effective alternative to whole-genome sequencing. Despite its extensive applications, the most technically complex and variable stage of the tNGS workflow remains target enrichment, a critical step that ensures target molecules are present at sufficiently high concentrations relative to background sequences. Enrichment methodologies are broadly classified into PCR-based and hybridization-based strategies, each offering distinct advantages and limitations. This review critically examines both approaches within the context of the computational challenges inherent to tNGS assay design, and surveys the full spectrum of established and emerging enrichment techniques, highlighting their suitability across different areas of molecular research and clinical diagnostics. The use of non‑canonical nitrogenous bases, circularization of linear DNA fragments, unique molecular identifiers (UMIs), and partially double‑stranded primers are among the many sophisticated approaches described in the review. We hope this review will contribute to accelerating the development of diagnostic strategies with targeted next-generation sequencing in the rapidly evolving field of molecular diagnostics.",
keywords = "Molecular diagnostics, Mutation detection, Next-generation sequencing, Primer design, tNGS",
author = "Maxim Koryukov and Regina Mikheeva and Andrey Kechin",
note = "The study was supported by the Russian state-funded project for ICBFM SB RAS (grant number 125041005115–5).",
year = "2026",
month = sep,
doi = "10.1016/j.ymeth.2026.05.004",
language = "English",
volume = "253",
pages = "31--48",
journal = "Methods",
issn = "1095-9130",
publisher = "Elsevier Science Publishing Company, Inc.",

}

RIS

TY - JOUR

T1 - Targeted next-generation sequencing techniques: From primer design to sophisticated library construction

AU - Koryukov, Maxim

AU - Mikheeva, Regina

AU - Kechin, Andrey

N1 - The study was supported by the Russian state-funded project for ICBFM SB RAS (grant number 125041005115–5).

PY - 2026/9

Y1 - 2026/9

N2 - Targeted Next-Generation Sequencing (tNGS) represents a cornerstone technology in modern clinical diagnostics and biological research. Widely adopted by clinical laboratories, tNGS provides a robust and cost-effective alternative to whole-genome sequencing. Despite its extensive applications, the most technically complex and variable stage of the tNGS workflow remains target enrichment, a critical step that ensures target molecules are present at sufficiently high concentrations relative to background sequences. Enrichment methodologies are broadly classified into PCR-based and hybridization-based strategies, each offering distinct advantages and limitations. This review critically examines both approaches within the context of the computational challenges inherent to tNGS assay design, and surveys the full spectrum of established and emerging enrichment techniques, highlighting their suitability across different areas of molecular research and clinical diagnostics. The use of non‑canonical nitrogenous bases, circularization of linear DNA fragments, unique molecular identifiers (UMIs), and partially double‑stranded primers are among the many sophisticated approaches described in the review. We hope this review will contribute to accelerating the development of diagnostic strategies with targeted next-generation sequencing in the rapidly evolving field of molecular diagnostics.

AB - Targeted Next-Generation Sequencing (tNGS) represents a cornerstone technology in modern clinical diagnostics and biological research. Widely adopted by clinical laboratories, tNGS provides a robust and cost-effective alternative to whole-genome sequencing. Despite its extensive applications, the most technically complex and variable stage of the tNGS workflow remains target enrichment, a critical step that ensures target molecules are present at sufficiently high concentrations relative to background sequences. Enrichment methodologies are broadly classified into PCR-based and hybridization-based strategies, each offering distinct advantages and limitations. This review critically examines both approaches within the context of the computational challenges inherent to tNGS assay design, and surveys the full spectrum of established and emerging enrichment techniques, highlighting their suitability across different areas of molecular research and clinical diagnostics. The use of non‑canonical nitrogenous bases, circularization of linear DNA fragments, unique molecular identifiers (UMIs), and partially double‑stranded primers are among the many sophisticated approaches described in the review. We hope this review will contribute to accelerating the development of diagnostic strategies with targeted next-generation sequencing in the rapidly evolving field of molecular diagnostics.

KW - Molecular diagnostics

KW - Mutation detection

KW - Next-generation sequencing

KW - Primer design

KW - tNGS

UR - https://www.scopus.com/pages/publications/105038628874

UR - https://www.mendeley.com/catalogue/5b33016f-e542-314b-93d7-262aacd7bf95/

U2 - 10.1016/j.ymeth.2026.05.004

DO - 10.1016/j.ymeth.2026.05.004

M3 - Article

VL - 253

SP - 31

EP - 48

JO - Methods

JF - Methods

SN - 1095-9130

ER -

ID: 79969318